Sedecal recalled one Mobile X-ray system on June 10, 2025, due to improper cleaning risks. The equipment is not water-resistant and can pose serious hazards if cleaned incorrectly. Users in California, Illinois, and New Jersey should stop using the device immediately.
Sedecal sent an email to its consignees to remind the users that the equipment is not water-resistant and must be cleaned strictly according to the instructions in the manual, clearly outlining the possible consequences of improper cleaning.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact SEDECAL SA or your healthcare provider for instructions. Notification method: E-Mail
The recalled product is the Mobile X-ray system, Model Number 40KW-FX.899. It was distributed in California, Illinois, and New Jersey. The unit is identified by UDI/DI 08436046002166 and Serial Number G72770.
The Mobile X-ray system is not water-resistant and requires strict adherence to cleaning instructions. Failure to clean according to the manual may lead to safety hazards.
No specific injuries or incidents have been reported related to this recall. However, the hazard level is classified as high.
Patients and healthcare providers should stop using the device immediately. Contact SEDECAL SA or your healthcare provider for further instructions.
For more information, contact SEDECAL SA via email. For additional resources, visit the FDA recall notice at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-0245-2026.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.